TAM for Lantheus presentation is 3B Usd by 2029 but I suspect this could grow, just depending on price. It is being used to monitor progress of disease and treatment so definitely not a one price item per person. I would think minimum 2 illuccix per person for those that have in multiple areas. Currently lantheus has 1B USD share and illuccix is 500m USD share. I disregard other competition for now as they have less marrket share. Still plenty of room to get market share for illuccix.
TAM for Lantheus presentation is 3B Usd by 2029 but I suspect...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
0.250(1.36%) |
Mkt cap ! $6.233B | |||
| Open | High | Low | Value | Volume |
| $18.56 | $18.81 | $18.43 | $49.28M | 2.643M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4262 | $18.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.68 | 1840 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| TLX (ASX) Chart |